Results 171 to 180 of about 16,042 (257)

Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response

, 2021
Dominika A. Kalkowska, Mark A. Pallansch, Steven G.F. Wassilak, Stephen L. Cochi, Kimberly M. Thompson   +4 more
openalex   +1 more source

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.

Lancet, 2021
Sáez-Llorens X, Bandyopadhyay AS, Gast C, Leon T, DeAntonio R, Jimeno J, Caballero MI, Aguirre G, Oberste MS, Weldon WC, Konopka-Anstadt JL, Modlin J, Bachtiar NS, Fix A, Konz J, Clemens R, Costa Clemens SA, Rüttimann R.   +17 more
europepmc   +1 more source

Increased Immunogenicity of Oral Poliovirus Vaccine Administered in Mass Vaccination Campaigns Compared with the Routine Vaccination Program in Jordan [PDF]

, 1997
M. R. Reichler, S. Kharabsheh, Philip Rhodes, H. Otoum, Susannah Bloch, M A Majid, Mark A. Pallansch, P. Patriarca, Stephen L. Cochi   +8 more
openalex   +1 more source

Review of: "Oral Polio Vaccine Is Unsafe for the World and Should Be Replaced with Inactivated Poliovirus Vaccine Globally" [PDF]

Osmond C. Ekwebelem
openalex   +1 more source

Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary [PDF]

, 2009
Beatrix Kapusinszky, Zsuzsanna Molnár, Katalin Szomor, György Berencsi   +3 more
openalex   +1 more source

Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial. [PDF]

Vaccine
Snider CJ, Zaman K, Estivariz CF, Aziz AB, Yunus M, Haque W, Hendley WS, Weldon WC, Oberste MS, Pallansch MA, Wassilak SGF, Anand A.   +11 more
europepmc   +1 more source

Immune predictors of oral poliovirus vaccine immunogenicity among infants in South India. [PDF]

NPJ Vaccines, 2020
Babji S, Manickavasagam P, Chen YH, Jeyavelu N, Jose NV, Praharaj I, Syed C, Kaliappan SP, John J, Giri S, Venugopal S, Kampmann B, Parker EPK, Iturriza-Gómara M, Kang G, Grassly NC, Uhlig HH.   +16 more
europepmc   +1 more source

[Vaccine-associated poliomyelitis: safety of the oral poliovirus vaccine, Brazil, 2013-2023Poliomielitis asociada a poliovirus derivados de la vacuna: seguridad de la vacuna oral contra la poliomielitis en Brasil, 2013-2023]. [PDF]

Rev Panam Salud Publica
Silva RMA, Kobayashi CD, Martins AF, Porto VBG, Araujo ACM, Andrade PHS, da Nóbrega MEB, Cabral CM, de Moraes MB, Ikeda do Carmo GM, Cardoso FD, de Siqueira GA, de Matos ZM, Percio J, Fernandes EG.   +14 more
europepmc   +1 more source

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa. [PDF]

Lancet Infect Dis, 2022
Cooper LV, Bandyopadhyay AS, Gumede N, Mach O, Mkanda P, Ndoutabé M, Okiror SO, Ramirez-Gonzalez A, Touray K, Wanyoike S, Grassly NC, Blake IM.   +11 more
europepmc   +1 more source

Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in Vietnam

, 2019
Đặng Thị Thanh Huyền, Ondrej Mach, Nguyễn Thành Trung, Phạm Quang Thái, Ho Vinh Thang, William C. Weldon, M. Steven Oberste, Visalakshi Jeyaseelan, Roland W. Sutter, Đặng Đức Anh   +9 more
openalex   +2 more sources